As Attached

Date: 31-08-2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596 Symbol: ERIS SUBJECT: OUTCOME OF THE BOARD MEETING HELD TODAY, i.e., MONDAY, AUGUST 31, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“SEBI Listing Regulations”) we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., Monday, August 31, 2026, inter alia, duly approved and took on record the following: ➢ Re-appointment of Mr. Sujesh Vasudevan as Independent Director of the Company Based on the recommendation of the Nomination & Remuneration Committee, the Board has considered and recommended to the members for their approval the re-appointment of Mr. Sujesh Vasudevan, as an Independent Director of the Company, for another period of 5 (Five) years commencing from July 25, 2027, up to July 24, 2032. ➢ Convening of 20th Annual General Meeting of the Members of the Company on Friday, September 25, 2026. The details as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. H0/49/14/14(7)2025-CFDPOD2/1/3762/2026 dated January 30, 2026, are given in the Annexure. The meeting of the Board of Directors commenced at 10:30 A.M. and concluded at 11:00 A.M. This is for your information and record. Thanking You, For Eris Lifesciences Limited Milind Talegaonkar Company Secretary & Compliance Officer Membership No: A26493 Annexure Re-appointment of Mr. Sujesh Vasudevan as Independent Director of the Company: Reason for change: Re-appointment Date of Re-appointment: July 25, 2027 Term of Re-appointment: 5 Years Brief Profile: Not Applicable Disclosure of relationships between directors: Not Applicable